Evidence map›Paper›PMID 32192451›Full record

ArticleBMC infectious diseases2020

Unusual accumulation of a wide array of antimicrobial resistance mechanisms in a patient with cytomegalovirus-associated hemophagocytic lymphohistiocytosis: a case report.

Mohammad Rubayet Hasan, Manu Somasundaram Sundaram, Sathyavathi Sundararaju, Kin-Ming Tsui, Mohammed Yousuf Karim, Diane Roscoe, Omar Imam, Mohammad A Janahi, Eva Thomas, Simon Dobson and 3 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Secondary hemophagocytic lymphohistiocytosis in children (Review).Experimental and therapeutic medicine · 2023
    Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Peritoneal Dialysis-Associated Peritonitis Caused byOpen forum infectious diseases · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Mohammad Rubayet HasanDepartment of Pathology, Sidra Medicine, Level 2M, Office H2M-24093, PO BOX 26999, Doha, Qatar. mhasan@sidra.org.
Manu Somasundaram SundaramDepartment of Pathology, Sidra Medicine, Level 2M, Office H2M-24093, PO BOX 26999, Doha, Qatar.
Sathyavathi SundararajuDepartment of Pathology, Sidra Medicine, Level 2M, Office H2M-24093, PO BOX 26999, Doha, Qatar.
Kin-Ming TsuiDepartment of Pathology, Sidra Medicine, Level 2M, Office H2M-24093, PO BOX 26999, Doha, Qatar.
Mohammed Yousuf KarimDepartment of Pathology, Sidra Medicine, Level 2M, Office H2M-24093, PO BOX 26999, Doha, Qatar.
Diane RoscoeDepartment of Pathology, Sidra Medicine, Level 2M, Office H2M-24093, PO BOX 26999, Doha, Qatar.
Omar ImamDepartment of Pathology, Sidra Medicine, Level 2M, Office H2M-24093, PO BOX 26999, Doha, Qatar.
Mohammad A JanahiDepartment of Pathology, Sidra Medicine, Level 2M, Office H2M-24093, PO BOX 26999, Doha, Qatar.
Eva ThomasDepartment of Pathology, Sidra Medicine, Level 2M, Office H2M-24093, PO BOX 26999, Doha, Qatar.
Simon DobsonDepartment of Pathology, Sidra Medicine, Level 2M, Office H2M-24093, PO BOX 26999, Doha, Qatar.
Rusung TanDepartment of Pathology, Sidra Medicine, Level 2M, Office H2M-24093, PO BOX 26999, Doha, Qatar.
Patrick TangDepartment of Pathology, Sidra Medicine, Level 2M, Office H2M-24093, PO BOX 26999, Doha, Qatar.
Andres Perez LopezDepartment of Pathology, Sidra Medicine, Level 2M, Office H2M-24093, PO BOX 26999, Doha, Qatar.
Qatar Airways (Qatar) · QAWeill Cornell Medical College in Qatar · QA

Funding

Sidra Medicine SIRF_200026Sidra Medicine SIRF_200040
6 · The paper itself

Abstract

backgroundInfections with multidrug-resistant organisms (MDRO) pose a serious threat to patients with dysregulated immunity such as in hemophagocytic lymphohistiocytosis (HLH), but such infections have rarely been comprehensively characterized. Here, we present a fatal case of HLH secondary to cytomegalovirus (CMV) infection complicated by both anti-viral drug resistance and sepsis from multiple MDROs including pandrug-resistant superbug bacteria. CASE PRESENTATION: A previously healthy, six-year-old boy presented with a 45-day history of fever prior to a diagnosis of hemophagocytic lymphohistiocytosis and hemorrhagic colitis, both associated with CMV. On hospital admission, the patient was found to be colonized with multiple, multidrug-resistant (MDR) bacteria including vancomycin-resistant enterococci (VRE) and carbapenamase-producing organisms (CPO). He eventually developed respiratory, urine and bloodstream infections with highly drug-resistant, including pandrug-resistant bacteria, which could not be controlled by antibiotic treatment. Antiviral therapy also failed to contain his CMV infection and the patient succumbed to overwhelming bacterial and viral infection. Whole genome sequencing (WGS) of the MDR bacteria and metagenomic analysis of his blood sample revealed an unusual accumulation of a wide range of antimicrobial resistance mechanisms in a single patient, including antiviral resistance to ganciclovir, and resistance mechanisms to all currently available antibiotics.

conclusionsThe case highlights both the risk of acquiring MDR superbugs and the severity of these infections in HLH patients.

Indexed as

Drug Resistance, Multiple, ViralAnti-Bacterial AgentsAntiviral AgentsCarbapenem-Resistant EnterobacteriaceaeChildCytomegalovirusCytomegalovirus InfectionsDrug Resistance, Multiple, BacterialFatal OutcomeGanciclovirGenotypeHumansLymphohistiocytosis, HemophagocyticMaleSepsisVancomycin-Resistant EnterococciAnti-Bacterial AgentsAntiviral AgentsGanciclovirAntiviral resistanceCytomegalovirusHemophagocytic lymphohistiocytosisMultidrug-resistant organism

Identifiers

PMID32192451
PMCPMC7083060
OpenAlexW3012431524

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.